Trial intelligence / Profile preview

Magnesium sulfate effects on uterine artery changes in severe pre-eclampsia

IRCT201108157341N1Phase 2Completed

Sponsor
Kermanshah University of Medical Sciences
Start
Mar 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of magnesium sulfate in preeclampsia, sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Uterine artery changes. Started Mar 2011; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

preeclampsia

Beyond the preview

Go deeper on IRCT201108157341N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201108157341N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call